The FDA has said that Bayer’s Trasylol increases the risk of death compared to similar drugs. Trasylol also known as aprotinin, is used in heart bypass surgery to stem excessive bleeding. The drug works by blocking enzymes that dissolve blood clots, hence less bleeding. However, the blood clots are a risk factor for heart attacks and death. Curiously, the FDA has stated a month earlier that the drug can remain on the market in spite of these risks.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.